Sentence examples for pediatric development from inspiring English sources

The search and inclusion and exclusion criteria were developed by an investigative team, including experts in the field of pediatric development and nutrient research.

ICH S11 on nonclinical safety studies to support a pediatric development program is expected to be completed in 2016 and implemented in 2018.

This chapters covers regulatory aspects of pediatric development, nonclinical safety guidelines, study design considerations, technical and logistical limitations of conducting neonatal/juvenile toxicity studies as well as the use of juvenile animal data in risk assessments.

Many young children in the US are reported to have physical activity and screen time behaviors that are inconsistent with recommendations for healthy pediatric development.

In supporting regulatory interactions, M&S supported dose justification, bioequivalence claims, label recommendations, timing of TQT study and optimizing (costly) QTc assessments in phase III, and pediatric development plans and doses.

Such factors may impose critical alterations in the key physiologic components of IBD pathogenesis during prenatal and/or pediatric development., One molecular process that can dynamically respond to nutritional changes in the gut mucosa is DNA methylation.

While the importance of healthy sleep to normal pediatric growth and development is widely acknowledged, there are cultural and parental differences regarding how sleep disordered behavior is defined and what are overall accepted pre-sleep activities.

To identify off-patent medications in need of further study, the BPCA asks the NICHD, in consultation with the FDA and experts in pediatric drug development, to develop a process for prioritizing needs in pediatric therapeutics by publishing a priority list.

This group of clinicians and scientists with a common interest in pediatric drug development and medicines-use systems developed a framework for developing drugs in dosage forms suitable for use in pediatric patients (Fig. 1).

The goal of this review is to highlight important challenges around pediatric drug development for psychiatric disorders, specifically during clinical development, and to present opportunities for filling these gaps, using new strategies for de-risking investigational drugs in new clinical trial designs/models.

Importantly, while pediatric drug development programs will continue to follow adult intervention development [ 29], the NIMH is now turning toward building a knowledge environment in which mentally ill youth are viewed as a key target population.